1. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.;Sokka;J Rheumatol,2002
2. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.;Wolfe;J Rheumatol,1990
3. Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.;Sany;J Rheumatol,1991
4. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study.;Weinblatt;Arthritis Rheum,1994
5. Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients.;Alarcon;Ann Rheum Dis,1995